Announced in May 2020, the Canada Research Continuity Emergency Fund (CRCEF) is part of the Government of Canada’s COVID-19 Economic Response Plan. The temporary program has been established to help sustain the research enterprise at Canadian universities and health research institutions that have been affected by the COVID-19 pandemic.
The CRCEF is being rolled out in 3 stages.
Stages 1 and 2
Stages 1 & 2 provides wage support to universities and health research institutions for up to 12 weeks to avert layoffs of research personnel. The support covered up to 75% of research personnel salaries funded through non-governmental sources incurred between March 15 and August 29, to a maximum of $847 per week per employee. Non-governmental sources are defined as funding sources including industry, foundations, not-for-profit, philanthropic funds, and international agencies. Eligibility for this funding was determined based on the extent to which research activities linked to non-governmental funding have been negatively impacted by COVID-19. Any reduced productivity or interruptions to employment (complete or partial) are considered negative impacts, including restriction of campus workspaces, suspension of funding, absences to care for family members, lack of access to research participants, increased risk related to COVID-19, etc.
Applications for Stage 1 and 2 funding are no longer being accepted.
Funding in Stage 3 supports direct costs of research that have been incurred to: (1) maintain essential research-related commitments during the COVID-19 pandemic; and (2) support ramping-up to full research activities as physical distancing measures are eased and research activities can resume.
The University of Lethbridge's notional allocation for Stage 3 is $296,699.